Citalopram 20 mg: Brand change

Brand change Active

From October 2022, a new brand of citalopram, Celapram, will be funded. The new tablets will look different, but the tablets have the same active ingredient and work in the body the same way as the currently funded citalopram, PSM citalopram.

Why is this happening?

The current supplier, API, is leaving the New Zealand market. Their PSM brand of citalopram is no longer being manufactured. We have sourced an alternative brand, Celapram, so people can continue to access their medicine. 

Key dates

1 October 2022:  Celapram listed on the Pharmaceutical Schedule (Pharmacode 2638738) 

December 2022: PSM citalopram likely to no longer be available (Pharmacode 2479621)

1 March 2023: PSM citalopram will be delisted from the Pharmaceutical Schedule 

Alternative brand listed

From October 2022, both brands of citalopram will be listed on the Schedule. 

Schedule listing for citalopram(external link) 

People using PSM citalopram will need to change to Celapram sometime before December 2022 to continue to access funded treatment. PSM citalopram is expected to begin running out in December 2022. From 1 March 2023, Celapram will be the only funded brand of citalopram. 

Celapram tablets look different but work the same way

Celapram has been thoroughly assessed by Medsafe, the medicines and devices safety authority, to ensure it is both safe, and works the same as other brands of citalopram. 

The packaging and tablets will look different, but the tablets have the same active ingredient and work in the body the same way. 

Celapram tablets are scored, which allows them to be broken in half to allow for 10 mg doses. 

Side by side comparison of both brands of citalopram. The PSM citalopram box is mostly hot pink. The tablets are oval with a score mark. Celapram box is mostly white with some green and yellow highlights. The tablets are rounder than PSM but still slightl.

Celepram has been available in Aotearoa New Zealand before, so it might look familiar to some people.

Translations

Te Reo Māori [PDF](external link)

Samoan [PDF](external link)

Chinese (Simplified) [PDF](external link)

Brand switch fee for pharmacists

We know that moving people from one brand to another can be difficult. To support this, we are covering the cost with a brand switch fee. This will be in place from 1 March 2023 to 1 June 2023. 

We know some patients and their whānau may have some questions to ask their pharmacists. This is an opportunity to provide some extra counselling to reassure people that Celapram works the same as PSM citalopram.

More about brand switch fees

Who to contact?

If you have any questions or concerns about this change, talk with your doctor, nurse or pharmacist. 

You can also get more information from us at enquiry@pharmac.govt.nz or 0800 660 050